Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
NDC 0002-8233, Insulin lispro, injection, suspension, from Eli Lilly and Company.
- Product NDC
- 0002-8233
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA021017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8233 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN LISPRO100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-8233-05 | 00002823305 | 5 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e49f701d-c19f-4cb2-b63f-01a917b33abcNADAC price for package 00002823305
GET /v1/drugs/nadac/00002823305
Use it
Look up 0002-8233 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8233 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-8233. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.